Light Horse Therapeutics, an innovative small molecule drug discovery firm based in San Diego, has recently secured $62 million in funding to accelerate its pioneering research in oncology therapeutics. Founded by a trio of esteemed academics—Brian Liau from Harvard, Ben Cravatt from Scripps, and Nathanael Gray from Stanford—the company leverages advanced tools from chemical and computational biology, as well as precision genome editing techniques. This strategic funding round, which includes contributions from existing backers including Versant Ventures and Mubadala Capital, aims to enhance the company’s capabilities in identifying functional and ligandable sites on high-value oncology protein targets for therapeutic intervention. With this capital infusion, Light Horse Therapeutics is set to advance its R&D efforts and expand its portfolio of drug candidates aimed at treating some of the most challenging cancers. The funding will not only bolster internal resources but also facilitate collaborations that could bring new, targeted therapies to market much faster. As Light Horse Therapeutics continues to push the boundaries of science and technology, their mission remains clear: to revolutionize cancer treatment and make a significant impact on patient outcomes. This latest financial milestone underscores the confidence investors have in the company's vision and its potential to transform the landscape of oncology therapeutics.
Light Horse Therapeutics Secures $62M in Series A Funding for Cutting-Edge Drug Discovery Technology
Recently funded · $62.0M Series aBiotechnology Research
Get the full Light Horse Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)